|Offre||198,85 x 1000|
|Vente||202,00 x 1000|
|Var. jour||199,62 - 202,40|
|Sur 52 semaines||173,45 - 248,87|
|Volume moyen||1 276 973|
|Bêta (mensuel sur 5 ans)||1,18|
|Rapport P/E (sur 12 mois)||S.O.|
|BPA (sur 12 mois)||S.O.|
|Date de bénéfices||S.O.|
|Dividende et rendement à terme||S.O. (S.O.)|
|Objectif sur 1 an||S.O.|
Before next-generation sequencing (NGS) came along, children and families with rare and undiagnosed genetic diseases often faced years-long diagnostic odysseys.
While visiting her grandparents in Florida, 17-year-old Kate frequented a pond near their house and spent time observing the various species of fish living there.
NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Illumina: At the Phoenix Convention Center in Arizona, representatives from Illumina, a global leader in DNA sequencing and array-based technologies, joined approximately 2000 molecular diagnostic ...
San Francisco Bay Area residents Jainu and Shruti Jogani had their newborn daughter, Reyna, at home for nearly three weeks when they noticed her exhibiting seizure-like symptoms-episodes so quick they weren't able to capture them on video. Standard blood work, MRI scans, and EKGs all came back normal, except for a gene panel for epilepsy.
Illumina, Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, announced a new research test for genitourinary pathogen and antimicrobial resistance (AMR) identification.
Advances in genomic studies have now permeated all aspects of our lives from agriculture to health and wellness. It is therefore becoming increasingly important to help the community understand these innovations so that they can navigate the increasingly complex realm of genomics. To this end, the outreach team at the Carl R.
"The Spoon Theory," a personal story by patient advocate Christine Miserandino, imagines "spoons" as a measurement of one's daily energy to illustrate what it's like to ration that energy.
For decades, cardiovascular disease has remained the number-one cause of death. In 2019 alone, nearly 18 million people around the world died from cardiovascular diseases (CVDs), which include disorders such as coronary heart disease, heart failure, and cerebrovascular disease.
Illumina CEO, Francis deSouza received the award for 3BL Media's 2022 Responsible CEO of the Year: Innovation and ESG Integration. 3BL Media presents Responsible CEO of the Year awards to corporate executives who embody leadership in delivering on their environmental, social, and governance (ESG) commitments.
Illumina, Inc. (NASDAQ:ILMN) announced that it will host its second annual virtual Environment, Social and Corporate Governance (ESG) focused investor event at 9:30 am Pacific Time (12:30 pm Eastern Time), Friday, October 28, 2022.
Australia's Centre for Population Genomics (CPG), a collaboration between the Garvan Institute of Medical Research and the Murdoch Children's Research Institute, has launched a new initiative to engage diverse communities in genomic research.
L'investissement de LifeArc, Illumina et Illumina Ventures financera des startups dans le domaine de la génomique pour les diplômés d'Illumina Accelerator CambridgeSAN DIEGO, 30 juin 2022/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), un leader mondial dans le séquençage de l'ADN et les technologies basées sur des réseaux, a annoncé aujourd'hui sa participation à Time Boost Capital I LP, un fonds de capital-risque en génomique de 30 millions de livres sterling destiné à fournir un financement équ